National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

thioredoxin-1 inhibitor PX-12
An orally bioavailable small molecule with potential antineoplastic activity. Thioredoxin-1 inhibitor PX-12 irreversibly binds to thioredoxin-1 (Trx-1) and inhibits its activity, which may result in growth inhibition and the induction of apoptosis. Overexpressed in many cancer cell types, the low molecular weight redox protein Trx-1 regulates transcription factor activity and inhibits apoptosis, promoting cell growth and survival; it also interacts with growth factors extracellularly to stimulate cell growth. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:PX-12
Chemical structure name:1-methylpropyl 2-imidazolyl disulfide



Previous:thiamine, Thibenzole, Thiofozil, thioguanine, Thioplex
Next:thiotepa, Thorazine, Thymectacin, thymidine, thymidine kinase-deleted vaccinia-hGM-CSF JX-594

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov